GREENWICH LIFESCIENCES, INC. Share Price
GREENWICH LIFESCIENCES, INC. (GLSI) had Share Price of $9.07 per share as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:SharePrice · last filed 2025-08-14
- 2025-06-30: Share Price $9.07.
- 2025-03-31: Share Price $9.54.
- 2024-12-29: Share Price $11.23.
- 2024-09-30: Share Price $14.37.
| Period end | Share Price |
|---|---|
| 2025-06-30 | $9.07 10-Q · filed 2025-08-14 |
| 2025-03-31 | $9.54 10-Q · filed 2025-05-20 |
| 2024-12-29 | $11.23 10-K · filed 2025-04-15 |
| 2024-09-30 | $14.37 10-Q · filed 2024-11-14 |
| 2024-06-28 | $17.26 10-Q · filed 2024-08-14 |
| 2024-03-28 | $19.94 10-Q · filed 2024-05-20 |
| 2023-12-29 | $10.52 10-K · filed 2024-04-15 |
| 2023-09-30 | $8.84 10-Q · filed 2023-10-19 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |